Biosynex Logo

Biosynex

Designs and distributes medical diagnostic solutions, including rapid tests and devices.

ALBIO | PA

Overview

Corporate Details

ISIN(s):
FR0011005933
LEI:
969500H4BGE1HBLGP566
Country:
France
Address:
22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN

Description

Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 18:00
BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS INC., FILIALE DE BIOSYNEX, RECOIT UNE S…
French 27.2 KB
2025-10-22 18:00
BIOSYNEX SA: RESULTATS SEMESTRIELS 2025
French 111.9 KB
2025-09-29 18:00
BIOSYNEX annonce louverture dune procedure de sauvegarde pour restructurer son …
French 20.4 KB
2025-09-25 18:00
BIOSYNEX SA: DEPOT DUNE DEMANDE DE PROCEDURE DE SAUVEGARDE POUR BIOSYNEX ET DUN…
French 28.7 KB
2025-07-29 18:45
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 28.7 KB
2025-07-17 18:00
BIOSYNEX SA: CHIFFRE DAFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M (-6%)
French 50.6 KB
2025-06-17 18:00
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
French 329.2 KB
2025-06-17 18:00
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 29.2 KB
2025-04-23 18:00
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 389.4 KB
2025-04-23 18:00
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 108.9 KB
2025-03-06 18:03
Franchissement de seuil
French 221.4 KB
2025-03-05 18:00
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 18:00
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB
2025-03-04 18:00
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 17:00
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB

Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biosynex

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biosynex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.